Certa Therapeutics
Developer of kidney disease treatments. The company's drugs block a receptor, a key driver of fibrosis (scarring) of the kidney which leads to kidney failure and ultimately dialysis or kidney transplantation. It uses genetic analysis to identify the.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
AUD50.0k | Grant | ||
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Certa Therapeutics
Edit
ACQUISITION by Certa Therapeutics Dec 2024